» Articles » PMID: 21409486

Two-stage Operation for High-risk Patients with Thoracic Esophageal Cancer: an Old Operation Revisited

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2011 Mar 17
PMID 21409486
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: An esophagectomy followed by reconstruction for esophageal cancer is a highly aggressive operation. The purpose of this study was to justify a two-stage operation for high-risk patients with esophageal cancer.

Methods: The clinical results of 27 patients who underwent two-stage operation were compared with 118 patients who underwent a simultaneous resection and reconstruction (control subjects). The reasons for the selection of the two-stage operation were underlying general disease in 13 patients (liver dysfunction, n = 6; pulmonary disease, n = 3; poor performance status, n = 2; diabetes and renal failure, n = 1 each) and high-risk operation in 14 other patients (colon interposition, n = 7; salvage operation after definitive chemoradiotherapy, n = 4; and intraoperative events, n = 3). The patients initially underwent an esophagectomy and a cervical esophagostomy. Reconstruction was usually performed 2-3 weeks later.

Results: The patients in the two-stage group were older than the control patients (mean 67.8 vs. 61.6 years old). The morbidity rate of the two-stage operation was 29.6%, which was not statistically different than control patients (32.2%). Postoperative complications in the two-stage operation were anastomotic leakage in 5 patients, and pneumonia and wound infection in 1 patient each. No patient experienced in-hospital death. The survival rates were not statistically different between the two groups.

Conclusion: A two-stage operation is a safe operation that prevents the occurrence of critical postoperative complications, and it thus may be considered an important treatment strategy for high-risk patients with esophageal cancer.

Citing Articles

Exploring the landscape of oesophageal discontinuity procedures and creation of cervical oesophagostomy in the modern era: a scoping review protocol.

Bondzi-Simpson A, Benipal H, Momoh H, Matei A, Wakeam E BMJ Open. 2024; 14(6):e081153.

PMID: 38862230 PMC: 11168122. DOI: 10.1136/bmjopen-2023-081153.


Successful multidisciplinary treatment for synchronous advanced esophageal and cecal cancers after total gastrectomy with reconstruction by jejunal interposition.

Sato Y, Tanaka Y, Yamamoto K, Horaguchi T, Fukada M, Sengoku Y World J Surg Oncol. 2024; 22(1):78.

PMID: 38486303 PMC: 10938683. DOI: 10.1186/s12957-024-03361-1.


Safe and curative modified two-stage operation for T4 esophageal cancer after definitive chemoradiotherapy: a case report.

Matsumoto T, Noma K, Maeda N, Kato T, Moriwake K, Kawasaki K Surg Case Rep. 2023; 9(1):119.

PMID: 37358692 PMC: 10293146. DOI: 10.1186/s40792-023-01692-x.


Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma.

Yagi K, Toriumi T, Aikou S, Yamashita H, Seto Y Ann Gastroenterol Surg. 2021; 5(4):436-445.

PMID: 34337292 PMC: 8316734. DOI: 10.1002/ags3.12448.


Successful two-stage operation for esophageal necrosis due to proton beam therapy followed by sorafenib in a case of large hepatocellular carcinoma.

Higaki E, Fukaya M, Miyata K, Kawai R, Abe T Surg Case Rep. 2020; 6(1):138.

PMID: 32548687 PMC: 7297925. DOI: 10.1186/s40792-020-00902-0.